Diagnosis, prevention and management of delirium: spot it, stop it, treat it
Year: 2024
Type: article
Abstract: SUMMARY Delirium frequently occurs among hospital in-patients, with significant attributable healthcare costs. It is associated with long-term adverse outcomes, including an eightfold increased risk of subsequent dementia. The purpose of this article is to inform clinicians of the best practices for spotting, stopping and treating delirium and provide guidance on common challenging clinical dilemmas. For spotting delirium, suggested screening tools are the 4 ‘A's Test (in general medical settings) and the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Prevention is best achieved with multicomponent interventions and targeted strategies focusing on: (a) avoiding iatrogenic causes; (b) brain optimisation by ensuring smooth bodily functioning; (c) maintaining social interactions and normality. Non-pharmacological approaches are the first line for treatment; they largely mirror prevention strategies, but the focus of empirical evidence is on prevention. Although sufficient evidence is lacking for most pharmacological approaches, an antipsychotic at low doses for short durations may be of utility for highly distressing or high-risk situations, particularly in hyperactive delirium, but only as a last resort.
Source: BJPsych Advances
DOI: 10.1192/bja.2024.57
Institutions: Mayo Clinic, The University of Queensland, Ochsner Medical Center, University of North Carolina at Chapel Hill, Forrest General Hospital, Sutter Health, Royal Brisbane and Women's Hospital, Queensland University of Technology, Prince Charles Hospital, Metro North Hospital and Health Service
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $2,845
OpenAlex ID: W4404043733
